BoneSupport Encouraged By Top-Line Data From CERTiFy Trial Of Cerament Bone Void Filler Injectable
• By Catherine Longworth
Results of the CERTiFy study demonstrate Bonesupport's Cerament bone-void filler is non-inferior to autograft in treating tibia plateau fracture defects. The company says the study marks a major milestone for its business and will change the standard of care for this kind of injury.
Top-line data from a key study show that BoneSupport Holding AB's synthetic bone graft Cerament is safe and effective for the treatment of tibia plateau fracture defects as autografts.
The Swedish orthobiologics company says the data suggest Cerament may "catalyse a change in the standard of care for this...
